• Biocodex was created in 1953 for the production and marketing of the first drug for the intestinal flora replacement, "Saccharomyces boulardii", available in France under the name ULTRA-LEVURE®.
• The range then expanded to include products developed by Biocodex, representing 45% of sales in France (at the end of 2007), and products acquired from other companies, redeveloped by Biocodex.
• French operations currently market 12 products.
• Biocodex works in three main therapeutic areas:
  • Gastroenterology, where it is the recognized international specialist in drugs for the intestinal flora replacement;
  • Neurology and Psychiatry, with an antidepressant, an anxiolytic and an antiepileptic;
  • Pain Treatment, with a range of general and local analgesics.

Last Updated : January 6, 2009

© 2009 Biocodex - All Rights Reserved

Terms of Use